Change - Announcement of Appointment::REDESIGNATION FROM NON-EXECUTIVE NON-INDEPENDENT DIRECTOR TO EXECUTIVE DIRECTOR - ZHU HUA

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Securities
BIOLIDICS LIMITED - SGXE89830751 - 8YY
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
12-Apr-2024 19:38:10
Status
New
Announcement Sub Title
REDESIGNATION FROM NON-EXECUTIVE NON-INDEPENDENT DIRECTOR TO EXECUTIVE DIRECTOR - ZHU HUA
Announcement Reference
SG240412OTHRYWY0
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
Re-designation of Mr. Zhu Hua from Non-Executive Non-Independent Director to Executive Director.

This announcement has been prepared by the Company and its contents have been reviewed by the Company's Sponsor, Evolve Capital Advisory Private Limited (the "Sponsor") for compliance with relevant rules of the Singapore Exchange Securities Trading Limited ("SGX-ST").

This announcement has not been examined or approved by the SGX-ST, and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement.

The details of the contact person for the Sponsor are: -

Name: Mr. Jerry Chua (Registered Professional, Evolve Capital Advisory Private Limited) and Mr. Tan Jun Yong (Registered Professional, Evolve Capital Advisory Private Limited)
Address :138 Robinson Road, Oxley Tower, #13-02, Singapore 068906
Tel :(65) 6241 6626

Additional Details

Date Of Appointment
11/04/2024
Name Of Person
Zhu Hua
Age
47
Country Of Principal Residence
China
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
Mr. Zhu Hua ("Mr. Zhu") is the Non-Executive Non-Independent Director of the Company and was appointed on 1 December 2023.

The Nominating Committee and the Board, having reviewed, considered, assessed and concluded that Mr. Zhu possesses the requisite experience, qualifications, skill sets and competencies to be an Executive Director of the Company, and have accordingly approved the re-designation of Mr. Zhu from Non-Executive Non-Independent Director to an Executive Director of the Company.
Whether appointment is executive, and if so, the area of responsibility
Appointment is executive. He will be responsible for the overall strategic direction, growth and business development of the Group.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director
Professional qualifications
1. Master of Science - International Securities Investment and Banking (University of Reading)

2. Bachelor of Economics - Investment Economics (Lanzhou University of Finance & Economics)
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
None
Conflict of interests (including any competing business)
None
Working experience and occupation(s) during the past 10 years
1. Zhenghe Antai (Beijing) Investment Management Co., Ltd (Director and General Manager - November 2006 to current)

2. Microbeam Software Technology (Shanghai) Limited (Director - September 2014 to November 2018)

3. Khorgos Weiniao Technology Limited (Supervisor - December 2018 to current)

4. Edge Mediatech Pte. Ltd. (Chief Financial Officer - February 2023 to current)

5. Biolidics Limited (Non-Executive Non-Independent Director - December 2023 to current)
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
98,500,000 ordinary shares in the issued share capital of the Company.
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
1. People's Cultural Heritage (Sichuan) Technology Co., Ltd
2. Khorgos Weiniao Technology Limited
Present
1. Zhenghe Antai (Beijing) Investment Management Co., Ltd
2. Shanghai Junlu Equity Investment Fund Management Limited
3. Shanghai Mobai Equity Investment Fund Management Limited
4. Jintai Zhenhe Investment (Beijing) Limited
5. HuaXing Wealth Holdings Limited
6. Microbeam Software Technology (Shanghai) Limited
7. Microbeam Interactive Holdings Limited
8. Microbeam International Holdings Limited
9. Microbeam International (Hongkong) Holdings Limited
10. Shanghai Banding Digital Technology Limited
11. Weiyu Software Technology (Beijing) Limited
12. Weiniao Network Technology (Beijing) Limited
13. Hainan Huashiwanli Network Technology Limited
14. Hainan Changyong Network Technology Limited
15. CESS Holdings Pte. Ltd.
16. Metaverse Technology (Chengdu) Co., Ltd
17. Biolidics Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Any prior experience as a director of an issuer listed on the Exchange?
Yes
If Yes, Please provide details of prior experience
Mr. Zhu is the Non-Executive Non-Independent Director of the Company prior to the re-designation, and he joined the Board since 1 December 2023.

Apart from his directorship in Biolidics Limited, Mr. Zhu has no prior experience as a director of other listed company on the Singapore Exchange Securities Trading Limited.

Mr. Zhu has completed the Listed Entity Directors Programme conducted by the Singapore Institute of Directors.
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Not applicable